Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Yan Bi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-7427-6219; OpenAlex author ID A5037038521, A5129933092. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
74
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 13

  1. Longitudinal body composition changes distinguish pancreatic ductal adenocarcinoma from controls in a pre-diagnostic CT cohort. Last author DOI 10.1016/j.pan.2026.09.008↗
  2. An Analysis of the Clinical Burden and Economic Costs of Venous Thromboembolism During Inpatient Admissions for Pancreatic Cancer in the United States. Co-author DOI 10.1177/10499091251341453↗
  3. Association Between Computed Tomography-Based AI-Derived Body Composition and Survival in Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.14309/ajg.0000000000003896↗
  4. AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication. Co-author DOI 10.1007/s00261-024-04775-x↗
  5. Protein N-Glycosylation Traits Combined with CA19-9 Accurately Distinguish Pancreatic Cancer Cases From Healthy Controls and Benign Pancreatic Diseases. Co-author DOI 10.1097/mpa.0000000000002517↗
  6. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1200/op.23.00447↗
  7. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. Co-author DOI 10.6004/jnccn.2023.7097↗
  8. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1158/1940-6207.capr-22-0529↗
  9. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detectio… Co-author DOI 10.1016/j.gie.2021.10.025↗
  10. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth. Co-author DOI 10.1016/j.pan.2022.03.019↗
  11. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Co… Co-author DOI 10.1053/j.gastro.2021.08.036↗
  12. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant. Co-author DOI 10.1097/mpa.0000000000001722↗
  13. Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. Co-author DOI 10.1016/j.ajpath.2014.06.023↗

Closest collaborators

The 25 strongest of 74 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael B. Wallace · 9 shared papers, 2021–2026 · strength 1.96
  2. Jeanin Elise van Hooft · 4 shared papers, 2024–2026 · strength 1.00
  3. Monique Esther van Leerdam · 4 shared papers, 2024–2026 · strength 1.00
  4. Derk C.F. Klatte · 4 shared papers, 2024–2026 · strength 1.00
  5. Aleksander M. Bogdanski · 3 shared papers, 2025–2026 · strength 0.80
  6. Massimo Raimondo · 2 shared papers, 2021–2026 · strength 0.48
  7. Frank Lukens · 1 shared paper, 2026 · strength 0.36
  8. Osayande Osagiede · 1 shared paper, 2026 · strength 0.36
  9. Jessica N. Everett · 3 shared papers, 2021–2024 · strength 0.33
  10. Aaron J. Grossberg · 3 shared papers, 2021–2024 · strength 0.33
  11. James M. Lindberg · 3 shared papers, 2021–2024 · strength 0.33
  12. Bryson W. Katona · 3 shared papers, 2021–2024 · strength 0.33
  13. Diane M. Simeone · 3 shared papers, 2021–2024 · strength 0.33
  14. Kasmintan A. Schrader · 3 shared papers, 2021–2024 · strength 0.33
  15. Teresa A. Brentnall · 3 shared papers, 2021–2024 · strength 0.33
  16. Andrew M. Lowy · 3 shared papers, 2021–2024 · strength 0.33
  17. Sonia S. Kupfer · 3 shared papers, 2021–2024 · strength 0.33
  18. Aimee Lee Lucas · 3 shared papers, 2021–2024 · strength 0.33
  19. Salvatore Paiella · 3 shared papers, 2021–2024 · strength 0.33
  20. Daniel C. Chung · 3 shared papers, 2021–2024 · strength 0.33
  21. George Zogopoulos · 3 shared papers, 2021–2024 · strength 0.33
  22. Jennifer B. Permuth · 3 shared papers, 2021–2024 · strength 0.33
  23. Fay Kastrinos · 3 shared papers, 2021–2024 · strength 0.33
  24. Che G. Ngufor · 1 shared paper, 2026 · strength 0.29
  25. Koen J.H. Wijsman · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.